OTC: ONTTF - Oxford Nanopore Technologies Limited

Yield per half year: -1.94%
Dividend yield: 0.00%
Sector: Healthcare

Oxford Nanopore Technologies Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 31.91 -100% -32.17 -100%
P/S 10.15 3.22 214.91%
P/BV 2.68 3.26 -17.86%
P/FCF -16.82 19.77 -185.09%
Ev/Ebitda -12.16 10.21 -219.13%
Ev/S 9.1 1.89 382.43%
Ev/FCF -10.43 17.78 -158.67%
E/P -0.0621 1.47 -104.23%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-74.84 24.68 -403.31% -64.19 +16.6%
ROE -24 13.16 -282.35%
ROA -19.88 6.08 -426.83%
ROIC -35.61 15.56 -328.87%
ROS -91.06 12.42 -833%
ROCE -26.19 15.07 -273.83%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.328 6.27 -105.23% -0.3392 -3.3%
Nеt Debt/Ebitda 1.41 -5.69 -124.75%
Debt/Ratio 0.0536 0.2171 -75.31%
Debt/Equity 0.0508 12.61 -99.6%
Debt/Net Income -0.2696 15.13 -101.78%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.73 -100% 0 0%
Number of years of dividend growth 0 1.3 -100%
DSI 0 0.7924 -100%
Average dividend growth 0 -247.24 -100%
Average percentage for 5 years 0 2.81 -100%
Average percentage for payments 0 247.93 -100%
Difference from average difference in sector -1.73

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
225.9 96.77 133.44%
Growth impulse Ebitda in 5 years 61.42 78.13 -21.39%
Growth impulse Net Income in 5 years 113.95 88.81 28.31%
Growth impulse FCF in 5 years 108.42 62.73 72.84%
Growth impulse EPS in 5 years 105.85 165.65 -36.1%
IP Score
4.62/10

Similar companies

Teligent, Inc.

Eisai Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

Roche Holding

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription